Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04120805 · ClinicalTrials.gov registry record · NA
Random Evaluation of Patients Who Have Had Laparoscopic Partial Nephrectomy
A NA study of Kidney Cancer, sponsored by University of Chicago.
- Active
- Registry status
- NA
- Development phase
- 178
- Enrollment target
- 1
- Study location
NCT04120805: Active NA study of Kidney Cancer, sponsored by University of Chicago.
NCT04120805 is a NA study of Kidney Cancer that is active but no longer recruiting, run by University of Chicago. The registered enrollment target is 178 participants, below the 877-participant average among 60 other Kidney Cancer trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04120805, a NA study of Kidney Cancer, is active but no longer recruiting, sponsored by University of Chicago.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 178 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the necessity of using hemostatic agents as a tool when performing robotic partial nephrectomy in the treatment of kidney cancer. This project asks whether patients who undergo robotic partial nephrectomy without the surgeon using hemostatic agents during the procedure will have the same, fewer, or more complications than when patients undergo this same surgery with the surgeon using hemostatic agents during the procedure.
Primary Outcome
The change in hemoglobin will be measured as the difference between the hemoglobin obtained postoperatively and the hemoglobin obtained preoperatively.
Conditions Studied
Interventions
- DEVICE Hemostatic Agent
- OTHER No Hemostatic Agent
Study Locations (1)
Illinois
- The University of Chicago - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 178 participants |
| Start Date | 2016-01-01 |
| Est. Completion | 2026-03-01 |
| Phase | NA |
What the registry record for NCT04120805 still lists
NCT04120805 is an interventional study that assigns participants to a tested intervention. The registered 178 participants enrollment target is mid-sized for trials with a published cap, below the 877-participant average among 60 other Kidney Cancer trials with a reported enrollment target (80% lower).
The record links to 1 condition, with Kidney Cancer appearing as the primary indexed condition, and to 2 interventions - of which Hemostatic Agent is the first listed.
NCT04120805 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT04120805 about?
NCT04120805 is a clinical study titled "Random Evaluation of Patients Who Have Had Laparoscopic Partial Nephrectomy". The purpose of this study is to evaluate the necessity of using hemostatic agents as a tool when performing robotic partial nephrectomy in the treatment of kidney cancer. This project asks whether patients who undergo robotic partial nephrectomy without the surgeon using hemostatic agents during the...
What is the current status of trial NCT04120805?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 178 participants. The study started on 2016-01-01. Estimated completion is 2026-03-01.
What conditions does trial NCT04120805 study?
This clinical trial studies the following conditions: Kidney Cancer.
What interventions are being tested in trial NCT04120805?
The interventions under investigation include: Hemostatic Agent (DEVICE), No Hemostatic Agent (OTHER).
Who is sponsoring clinical trial NCT04120805?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04120805 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Kidney Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04120805's enrollment target sits among peer trials
178 18th of 60 higher than 43 of 60 other Kidney Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Kidney Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Patient Navigation Program to Improve Clinical Trial Enrollment in Cancer Patients
RECRUITING · NA
-
An Investigation of Kidney and Urothelial Tumor Metabolism in Patients Undergoing Surgical Resection and/or Biopsy
RECRUITING · NA
-
Improving Nutrition and Physical Activity for Cancer Survivors (Tools To Be Fit)
RECRUITING · NA
-
A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest
RECRUITING · NA
-
Designing Visual Tools to Enhance Cancer Surgeon Decision-making
RECRUITING · NA
-
Integrated Actionable Aging Assessment for Cancer Patients Pilot
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03642002 · 178 participants · NA
The Effects of Music Therapy on Adult Patients Requiring Mechanical Ventilation in the ICU
- NCT04227847 · 178 participants · Phase 1
A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies
- NCT04855214 · 178 participants
Evaluating the Experience of Upper Limb Prosthesis Use
- NCT05391126 · 178 participants · NA
GENOCARE: A Prospective, Randomized Clinical Trial of Genotype-Guided Dosing Versus Usual Care
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI